Evolus (EOLS) Stock Chart & Stock Price History $7.43 +0.20 (+2.77%) Closing price 08/21/2025 04:00 PM EasternExtended Trading$7.44 +0.01 (+0.13%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Evolus Stock Price Performance The Evolus (EOLS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 52.00%, with a year-to-date return of -32.70%. In the past month, the stock has decreased 22.36%, reflecting recent market activity. As of the latest close, Evolus traded at $7.43 with a market cap of $480.57 million and volume of 838,854 shares. Five years ago, the stock traded at $3.55, representing a 109.30% increase over that period. At the time, it had a market cap of $130.94 million and a volume of 181,400 shares. Receive EOLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.40%1 Month Performance-22.36%3 Month Performance-22.28%Year-To-Date Performance-32.70%1 Year Performance-52.00%5 Year Performance+109.30% EOLS Stock Chart for Friday, August, 22, 2025 EOLS Chart by TradingView Evolus Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$7.23$7.43+2.77%$7.50$7.17838,854 shs$480.57 million08/20/2025$7.13$7.23+1.40%$7.27$6.881.12 million shs$467.64 million08/19/2025$6.69$7.13+6.58%$7.26$6.881.38 million shs$461.20 million08/18/2025$6.73$6.69-0.59%$6.82$6.55987,331 shs$432.71 million08/15/2025$6.40$6.73+5.16%$6.94$6.431.07 million shs$435.30 million08/14/2025$6.51$6.40-1.69%$6.45$6.211.44 million shs$413.95 million08/13/2025$6.40$6.51+1.72%$6.74$6.291.64 million shs$421.10 million08/12/2025$5.77$6.40+10.92%$6.46$5.831.83 million shs$413.95 million08/11/2025$5.90$5.77-2.20%$5.97$5.712.18 million shs$373.20 million08/08/2025$6.07$5.90-2.80%$6.08$5.862.72 million shs$381.61 million Get the Latest News and Ratings for EOLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$6.37$6.07-4.71%$6.49$5.973.61 million shs$391.39 million08/06/2025$8.91$6.37-28.51%$6.76$5.8513.69 million shs$410.74 million08/05/2025$9.11$8.91-2.20%$9.15$8.734.33 million shs$574.52 million08/04/2025$9.15$9.11-0.44%$9.35$8.891.47 million shs$587.41 million08/01/2025$8.92$9.15+2.58%$9.18$8.651.70 million shs$589.99 million07/31/2025$8.96$8.92-0.45%$9.29$8.761.24 million shs$575.13 million07/30/2025$9.25$8.96-3.14%$9.36$8.911.39 million shs$577.74 million07/29/2025$9.28$9.25-0.32%$9.42$9.19878,793 shs$596.44 million07/28/2025$9.53$9.28-2.62%$9.58$9.25687,832 shs$598.34 million07/25/2025$9.65$9.53-1.24%$9.72$9.001.48 million shs$614.46 million07/24/2025$9.58$9.65+0.73%$10.20$9.491.92 million shs$622.23 million07/23/2025$9.57$9.58+0.10%$9.85$9.52899,339 shs$617.72 million07/22/2025$9.22$9.57+3.80%$9.69$9.18800,935 shs$617.04 million07/21/2025$9.20$9.22+0.22%$9.41$9.18619,953 shs$594.51 million Related Companies Travere Therapeutics Stock Chart Biohaven Stock Chart Aurinia Pharmaceuticals Stock Chart Schrodinger Stock Chart Evotec Stock Chart Janux Therapeutics Stock Chart 89BIO Stock Chart Edgewise Therapeutics Stock Chart WAVE Life Sciences Stock Chart AbCellera Biologics Stock Chart Receive EOLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EOLS) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access